Enterococcus News and Research

RSS

Lung microbiome plays major role in asthma severity and response to treatment

While the microbiome has gained significant attention for its impact on digestive health in recent years, its effect on lung disease has largely remained unstudied.

24 Oct 2017

Common acid reflux drugs linked to progression of chronic liver disease

Approximately 10 percent of the general population take a proton pump inhibitor (PPI) drug to block stomach acid secretions and relieve symptoms of frequent heartburn, acid reflux and gastroesophageal reflux disease.

10 Oct 2017

Antibiotic-resistant bacteria work together to cause infection, research suggests

What's worse than getting exposed to a kind of bacteria that modern antibiotics can't kill? Getting exposed to more than one - because they may work together to cause an infection, new research suggests.

12 Sep 2017

Breast milk protective against bacterial infections

A new study has found that the complex mixture of sugars, proteins and fats in mother’s milk possesses certain properties that can protect babies against bacterial infections like Streptococci too. Researchers from Vanderbilt University looked at the antibacterial properties of breast milk and found that the sugars in it have antibacterial properties and also work to enhance the antibacterial properties of the proteins in breast milk.

21 Aug 2017

Amped up antibiotic to fight resistant bacteria finally a reality

Resistant bacteria have been a menace killing thousands worldwide. Bacteria causing pneumonia, tuberculosis, wound and skin infections, gonorrhea have notably undergone major changes to evade the current armament of antibiotics that physicians have to fight them with.

30 May 2017

Scientists develop new drug that combats two ‘priority pathogens’

Scientists at St. Boniface Hospital Albrechtsen Research Centre and the University of Manitoba have developed a drug that combats 2 of the top 10 "priority pathogens" recently defined by the World Health Organization as antiobiotic-resistant bacteria requiring new interventions.

20 Apr 2017

Antimicrobial protein reduces creamy white lesions linked to oral thrush in mouse models

An antimicrobial protein caused a dramatic reduction in the creamy white lesions associated with oral thrush in a preclinical study, report microbiologists with McGovern Medical School at The University of Texas Health Science Center at Houston.

11 Apr 2017

CSU chemists create simple, cheap testing systems to detect water or food-borne pathogens

Food poisoning: Many of us have had it, and we won't soon forget it. Colorado State University chemists are trying to make it so we can.

8 Mar 2017

Scientists move closer towards simpler, accurate detection of bacterial contaminants in food and water

Food poisoning is a scourge. Yet preventing it is far from foolproof. But in a new study in Analytical Chemistry, scientists report that they are closing in on a way to use a combination of color-changing paper and electrochemical analysis -- on plastic transparency sheets or simple paper -- to quickly, cheaply and more accurately detect bacterial contamination of fruits and vegetables in the field before they reach grocery stores, restaurants and household pantries.

8 Mar 2017

Persistent infection in infant reveals mutation that helps bacteria tolerate antibiotic therapy

The quest to understand a prolonged infection in an infant being treated for leukemia has led to the St. Jude Children's Research Hospital discovery of a mutation that allows bacteria to tolerate normally effective antibiotic therapy. The report appears today in the scientific journal mBio.

3 Jan 2017

Portable detection system can rapidly identify virulent, multi-drug resistant pathogens in remote areas

A team of researchers has developed a portable detection system that can rapidly identify some of the most virulent, often multi-drug resistant pathogens.

16 Dec 2016

International travellers may spread antimicrobial-resistant bacteria in their home countries, study reveals

Airports are international travel hubs visited by large numbers of people. London Heathrow, for example, has an average of 205,400 travellers every day and saw 75 million people arriving and departing from all over the world in 2015.

3 Nov 2016

Antimicrobial copper touch surfaces may help fight global threat of antibiotic resistance

A key presentation at the Infection Control show within the Patient First conference on 22 November will look at a simple engineering solution to help fight the global threat of antibiotic resistance: antimicrobial copper touch surfaces.

21 Oct 2016

Study shows how common intestinal microbe protects the gut from attack by harmful bacteria

Antibiotics save millions of lives. But their tendency to kill helpful and harmful bacteria alike, coupled with the growing problem of antibiotic resistance, means that they are not without their downside.

4 Oct 2016

Penicillin allergy testing: an interview with Dr. Eric Macy

Penicillin was one of the first antibiotics developed and has saved millions of lives. First used in the early 1940s, penicillin is still one of the most widely used and least toxic family of antibiotics.

17 Aug 2016

Novel method uses light-activated nanodrug to help fight antibiotic-resistant infections

A research team led by University of Arkansas chemist Jingyi Chen and University of Arkansas for Medical Sciences microbiologist Mark Smeltzer has developed an alternative therapeutic approach to fighting antibiotic-resistant infections.

2 Apr 2016

Research shows probiotic B. longum KACC 91563 has ability to reduce effects of food allergies

Lactobacillus might sound familiar when the topic of probiotics comes up, but they are only one of many types of bacteria that have proven health benefits.

16 Mar 2016

Naturally occurring clay exhibits potent antibacterial activity against ESKAPE pathogens

Naturally occurring clay from British Columbia, Canada -- long used by the region's Heiltsuk First Nation for its healing potential -- exhibits potent antibacterial activity against multidrug-resistant pathogens, according to new research from the University of British Columbia.

27 Jan 2016

FDA approves Allergan's sNDA to update label for DALVANCE (dalbavancin) for injection

Allergan plc, a leading global pharmaceutical company, today announced the U.S. Food and Drug Administration has approved the company's supplemental new drug application (sNDA) to update the label for DALVANCE (dalbavancin) for injection.

21 Jan 2016

Paratek initiates Omadacycline phase 3 clinical study in community acquired bacterial pneumonia (CABP)

Paratek Pharmaceuticals, Inc. has announced the dosing of the first patient in its Phase 3 clinical study of its lead drug candidate, omadacycline, for the treatment of Community Acquired Bacterial Pneumonia (CABP). This global Phase 3 study will assess the efficacy and safety of omadacycline compared with moxifloxacin in subjects with CABP.

9 Nov 2015